Montelukast Prescribing at PROSPECT SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,295
Total Quantity
30.7K
NHS Cost
£1.5K
vs National Avg
+89.1%
PROSPECT SURGERY prescribed 1,295 items of Montelukast over the last 12 months at a cost of £1,468 to the NHS. This is 89.1% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
107
Jun 2026
97
Jun 2026
125
Jun 2026
106
Jun 2026
104
Jun 2026
110
Jun 2026
112
Jun 2026
114
Jun 2026
109
Jun 2026
103
Jun 2026
102
Jun 2026
106
Prescribing Details
| Total Items | 1,295 |
|---|---|
| Total Quantity | 30,723 |
| Total NHS Cost | £1,468 |
| Presentations | 3 different forms |
| vs National Average | +89.1% |
Montelukast Prescribing Comparison
| This practice | 1,295 items |
|---|---|
| National average per practice | 685 items |
| Difference | +89.1% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.